Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Health

Moderna completes case accrual for interim analysis of COVID-19 vaccine

FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020. REUTERS/Brian Snyder

Moderna Inc <MRNA.O> said on Wednesday it has completed case accrual for the first interim analysis of the late-stage trial of its COVID-19 vaccine candidate.

The company said data on these cases is being prepared for submission to the independent Data Safety Monitoring Board for analysis and recommendation.

Moderna expects the first interim analysis to include more than 53 cases.

(Reporting by Mrinalika Roy in Bengaluru; Editing by Arun Koyyur)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.